Amplifier Health, creator of a revolutionary acoustic AI that decodes health signals hidden within the human voice today announced a landmark strategic partnership with Xeomics, a global leader in precision medicine and healthcare data acceleration.
Amplifier Health, the leading digital AI company and developer of a revolutionary acoustic AI that decodes health signals hidden within the human voice today announced a landmark strategic partnership with Xeomics, a global leader in precision medicine and healthcare data acceleration. This collaboration grants Amplifier Health exclusive access to vital voice data from over 750,000 patients across 3 diverse global markets.
This partnership represents a quantum leap in gathering the diverse, real-world data needed to build truly equitable and globally effective diagnostic tools, furthering Amplifier’s mission to make better health radically accessible. Access to diverse, large-scale, real-world data enables precise training of Amplifier’s Large Acoustic Model which analyzes acoustic features – the subtle patterns in pitch, tone, rhythm, and breath – to detect signals for 35+ medical conditions and 7+ wellness indicators. The Xeomics collaboration provides varied data needed – encompassing multiple languages, dialects, accents, background environments, and health statuses to ensure Amplifier’s groundbreaking technology is not only effective but also equitable and fair for global populations, mitigating biases often found in less diverse datasets and unlocking insights relevant across a wider range of conditions.
Health Technology Insights: EUCALIA and Hippocratic AI Launch First Japanese Generative AI Healthcare Agent
“Training a truly transformative AI requires data that reflects the real world in all its complexity,” said Dr. Amit Mehta, MD, CEO of Amplifier Health. “Partnering with Xeomics gives us unique access to incredibly rich, diverse datasets spanning three continents. This is a critical accelerator for our roadmap.”
Xeomics’ expertise lies in navigating international healthcare systems to facilitate access to bespoke patient data cohorts rapidly and ethically. This capability significantly shortens Amplifier Health’s data acquisition timelines and demonstrates Amplifier Health’s ability to execute on its strategy of securing unique, large-scale data assets essential for building a category-defining AI.
Health Technology Insights: CueZen Raises $5million Seed Round to Fuel Personalized Healthcare Solutions
“Xeomics is dedicated to empowering healthcare innovators like Amplifier Health by accelerating the precision medicine journey,” added George Zarkadakis, Chief Innovation Officer of Xeomics. “Amplifier’s focus on acoustic biomarkers represents the cutting edge of voice diagnostics, and providing this scale of diverse data will significantly accelerate their path to impacting patient outcomes globally. We are thrilled to facilitate access to these unique datasets through our global network.”
Securing this critical data significantly de-risks Amplifier’s technical roadmap and strengthens its competitive moat, solidifying its leadership position in the race to define the future of voice-based health.
Health Technology Insights: Pager Health Launches AI Wellness Agent for Data-Driven Health Experience
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – PR Web
